推薦產(chǎn)品
2-hydroxy-2-(pyrrolidin-2-yl)aceticacid 5-hydroxy-3,3-dimethyldihydrofuran-2(3H)-one methyl3-oxo-4-m-tolylbutanoate ethyl3-oxo-4-o-tolylbutanoate methyl2,4-dioxopentanoate 1H-pyrazolo[3,4-b]pyridine-3-carboxylicacid 5-(2,2,2-trifluoroethoxy)picolinicacid 2,3-dihydroxyterephthalicacid 4-(tert-butoxycarbonyl)morpholine-2-carboxylicacid 2-(4-fluorobenzyloxy)aceticacid 2-(2-fluorocyclohexyloxy)aceticacid 2-(tetrahydro-2H-pyran-4-yloxy)aceticacid 2-(pyridin-4-ylmethoxy)aceticacid 2-(cyclopentyloxy)aceticacid 2-(pyrazin-2-ylmethoxy)aceticacid 2-((4-(trifluoromethyl)pyridin-3-yl)methoxy)aceticacid 2-(pyridazin-3-yloxy)aceticacid 2-(pyridin-2-ylamino)aceticacid 2-(1H-pyrrolo[3,2-b]pyridin-3-yl)aceticacid 2-(1H-pyrrolo[2,3-c]pyridin-3-yl)aceticacid 2-(2-methyl-1H-imidazol-1-yl)aceticacid 2-(1H-indol-3-yl)propanoicacid 2-(1H-indol-1-yl)aceticacid 2-(1H-1,2,3-triazol-1-yl)aceticacid 2-(1H-benzo[d][1,2,3]triazol-1-yl)aceticacid ethyl2-bromo-2-phenylacetate ethyl2-bromo-2-(2-bromophenyl)acetate 1-(tert-butoxycarbonyl)azetidine-3-carboxylicacid 1-(benzyloxycarbonyl)pyrrolidine-3-carboxylicacid 1-tert-butyl3-methylazetidine-1,3-dicarboxylate 2-methylpyrido[2,3-b]pyrazin-3(4H)-one isothiazol-4-aminehydrochloride tert-butyl2-oxa-7-azaspiro[3.5]nonane-7-carboxylate 2-oxa-7-azaspiro[3.5]nonane 4-hydrazinylpyridin-2(1H)-one (7H-pyrrolo[2,3-d]pyrimidin-4-yl)methanaminehydrochloride 1-cyclopropylpiperazine 7-oxa-2-azaspiro[3.5]nonanehydrochloride 4,4-difluorocyclohexanaminehydrochloride 4-(1,3,4-oxadiazol-2-yl)aniline 4-(1,2,4-oxadiazol-3-yl)aniline 3,4-dihydro-2H-benzo[b][1,4]oxazine 3-(1-methyl-1H-pyrazol-4-yl)aniline piperazin-2-one methylpyrrolidine-3-carboxylate 2-(8-fluoronaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 6-(dimethylamino)-4-methylpyridin-3-ylboronicacid 3-bromo-7-chloro-5-methyl-1H-pyrazolo[4,3-b]pyridine 7-chloro-5-methyl-1H-pyrazolo[4,3-b]pyridine 5-bromo-3,3-dimethylindolin-2-one 市場行情 盤面情況：SM2105合約大幅上漲，最高報7498，最低報7218，收盤7482，較上一交易+5.17%；持倉112011手，+7586；基差-582，-242；SM9-5月價差-64，-12。
消息：中鋼協(xié)數(shù)據(jù)顯示，2月上旬，20個城市5大品種鋼材社會庫存1134萬噸，環(huán)比增加161萬噸，上升16.5%，近期庫存快速回升；比年初增加404萬噸，上升55.3%；比去年同期減少337萬噸，下降22.9%
市場報價：內(nèi)蒙古硅錳FeMn68Si18出廠均價報6900元/噸，較上一交易日持平；貴州硅錳FeMn68Si18出廠均價報7050元/噸，較上一交易日持平；云南硅錳FeMn68Si18出廠均價報7000元/噸，較上一交易日持平。
倉單庫存：鄭商所錳硅倉單日報為4495張，+0。
主力持倉：當(dāng)日主力合約前20名多頭持倉量69063手，+3699；空頭持倉量82139手，+3871；凈空13076手，+172。
總結(jié)：國內(nèi)硅錳盤整運行。受內(nèi)蒙限電限產(chǎn)影響，后市繼續(xù)增產(chǎn)受限。節(jié)后鋼廠需求預(yù)期樂觀，3月鋼招即將來臨。在生產(chǎn)受限的前提下，錳硅市場需求預(yù)期良好。但錳礦原料端支撐不足，價格上漲或有一定壓力。技術(shù)上，SM2105合約大幅上漲，MACD指標(biāo)顯示綠色動能柱轉(zhuǎn)紅，“金叉”形成，短線走勢偏強。操作上，建議在7200元/噸附近短多，止損參考7120元/噸。
